BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38627808)

  • 41. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.
    Tabrizian P; Shrager B; Jibara G; Yang MJ; Romanoff A; Hiotis S; Sarpel U; Labow DM
    J Gastrointest Surg; 2014 May; 18(5):1024-31. PubMed ID: 24577736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no?
    Williams BH; Alzahrani NA; Chan DL; Chua TC; Morris DL
    Eur J Surg Oncol; 2014 Aug; 40(8):943-9. PubMed ID: 24378009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
    Chua TC; Quinn LE; Zhao J; Morris DL
    J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Summary of current therapeutic options for peritoneal metastases from colorectal cancer.
    Chua TC; Esquivel J; Pelz JO; Morris DL
    J Surg Oncol; 2013 May; 107(6):566-73. PubMed ID: 22688776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.
    Votanopoulos KI; Ihemelandu C; Shen P; Stewart JH; Russell GB; Levine EA
    J Am Coll Surg; 2012 Sep; 215(3):412-7. PubMed ID: 22634117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
    J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.
    Bretcha-Boix P; Farré-Alegre J; Sureda M; Dussan C; Pérez Ruixo JJ; Brugarolas Masllorens A
    Clin Transl Oncol; 2010 Jun; 12(6):437-42. PubMed ID: 20534399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival of patients with pseudomyxoma peritonei treated by serial debulking.
    Järvinen P; Järvinen HJ; Lepistö A
    Colorectal Dis; 2010 Sep; 12(9):868-72. PubMed ID: 19519686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.
    Cao C; Yan TD; Black D; Morris DL
    Ann Surg Oncol; 2009 Aug; 16(8):2152-65. PubMed ID: 19434455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment.
    Ceelen WP; Bracke ME
    Lancet Oncol; 2009 Jan; 10(1):72-9. PubMed ID: 19111247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.
    Bijelic L; Yan TD; Sugarbaker PH
    J Surg Oncol; 2008 Sep; 98(4):295-9. PubMed ID: 18726900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer.
    Morice P; Dubernard G; Rey A; Atallah D; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Dec; 197(6):955-63. PubMed ID: 14644284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of peritoneal-surface malignancy: the surgeon's role.
    Sugarbaker PH
    Langenbecks Arch Surg; 1999 Dec; 384(6):576-87. PubMed ID: 10654274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features.
    Portilla AG; Sugarbaker PH; Chang D
    World J Surg; 1999 Jan; 23(1):23-9. PubMed ID: 9841759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review.
    Sarofim M; Wijayawardana R; Ahmadi N; Morris DL
    World J Surg Oncol; 2024 Apr; 22(1):99. PubMed ID: 38627808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
    Narasimhan V; Tan S; Kong J; Pham T; Michael M; Ramsay R; Warrier S; Heriot A
    Colorectal Dis; 2020 Nov; 22(11):1482-1495. PubMed ID: 32027455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.